期刊文献+

PLF联合榄香烯注射液治疗恶性胸腔积液的疗效分析 被引量:4

The effect analysis of PLF combined with elemene on malignant pleural effusion
下载PDF
导出
摘要 目的探讨PLF联合榄香烯注射液治疗恶性胸腔积液的疗效。方法选取我科2011年3月至2016年3月收治的恶性胸腔积液52例为研究对象,随机分为I组(榄香烯注射液+顺铂+亚叶酸钙+氟脲嘧啶)和II组(顺铂+亚叶酸钙+氟脲嘧啶)各26例,比较两组疗效、KPS评分、不良反应发生情况。结果治疗4周后,I组有效率为84.6%,显著高于II组的57.7%(P<0.05);I组KPS评分为(78.7±3.2)分,显著高于II组的(71.5±4.1)分(P<0.05);I组不良反应发生率为30.8%,II组不良反应发生率为34.6%,组间比较差异无统计学意义(P>0.05)。结论榄香烯联合PLF治疗恶性胸腔积液安全有效,可在临床广泛应用。 Objective To investigate the effect of PLF combining elemene on malignant pleural effusion. Methods Fifty- two cases of patients with MPE were selected and divided into I group (26 cases, elemene+PLF) and II group (26 cases, PLF), the curative effect between two groups were compared between two groups. Results The effective rate (84.6%) and KPS score (78.7±3.2) were significantly better in I group than II group of 57.7% and 71.5±4.1 respectively (P〈O.05), but the adverse reaction rate had no significant difference between I group with 30.8% and II group with 34.6% (P〉0.05). Conclusion PLF combining elemene has a safety and great effect on MPE.
作者 刘赞
出处 《临床医学研究与实践》 2016年第19期51-52,共2页 Clinical Research and Practice
  • 相关文献

参考文献9

二级参考文献44

  • 1师国强.榄香烯乳胸腔内注射治疗恶性胸腔积液的疗效观察[J].实用诊断与治疗杂志,2007,21(5):373-374. 被引量:22
  • 2Glimelius B, Hoffman K, Graf W, et al. Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group [J]. Cancer, 1994, 73(3) :556 -562. 被引量:1
  • 3Pazdur R, Vincent M. Raltitrexed (Tomudex) versus 5-fluorouracil and leucovorin (5FU + LV) in patients with advanced colorectal cancer (ACC) : resuhs of a randomized, multicenter, North American trial [ C]. Denver:Proc Am Soc, 1997 :a801. 被引量:1
  • 4Cocconi G, Cunningham D, Van Cutsem E, et al. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group [ J ]. J Clin Oncol, 1998, 16(9) : 2943 -2952. 被引量:1
  • 5Cunningham D, Zalcberg JR, Rath U, et al. Final results of a randomised trial comparing Tomudex ( raltitrexed ) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. 'Tomudex' Colorectal Cancer Study Group [J]. Ann Oncol, 1996, 7(9) : 961 - 965. 被引量:1
  • 6Maughan T, James R, Kerr D, et al. Excess treatment related deaths and impaired quality of life show raltitrexed is inferior to infusional 5FU regimen in the palliative chemotherapy of advanced colorectal cancer ( CRC ) : final results of MRC CRO6 [J]. Ann Oncol, 2000, 11(Suppl4): a1850. 被引量:1
  • 7Cortinovis D, Bajetta E, Di Bartolomeo M, et al. Raltitrexed plus oxaliplatin in the treatment of metastatic colorectal cancer [J]. Tumori, 2004, 90(2):186- 191. 被引量:1
  • 8Laudani A, Gebbia V, Leonardi V, et al. Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil-refractory metastatic colorectal adeno-carcinoma [J]. Anticancer Res, 2004, 24 (2C) :1139 - 1142. 被引量:1
  • 9Santini D, Massacesi C, D'Angelillo RM, et al. Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: a multicenter non-randomized phase Ⅱ study [J]. Med Oncol, 2004, 21 ( 1 ) :59 -66. 被引量:1
  • 10Martoni A, Mini E, Pinto C, et al. Oxaliplatin plus rahitrexed in the treatment of patients with advanced colorectal cancer: a phase Ⅱ study [J]. AnticancerRes, 2003, 23(1B):687-691. 被引量:1

共引文献311

同被引文献43

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部